U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07578727) titled 'Photon Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma' on May 05.
Brief Summary: Proton therapy for nasopharyngeal carcinoma can reduce radiotherapy-related toxic reactions, and some retrospective studies have found that proton therapy improves the survival of patients with nasopharyngeal carcinoma. However, high-level prospective clinical evidence is still lacking. This study aims to investigate the efficacy and side effects of proton therapy compared with photon intensity-modulated radiotherapy for nasopharyngeal carcinoma through a multicenter, prospective, phase III clinical trial, providing more high-quality evide...